Adjuvant Holdings Co (TSE:4929) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4929 Adjuvant Holdings Co Ltd TSE:4929
62 GF Score
Price 円745.00
GF Value 円711.32
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Adjuvant Holdings Co Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Adjuvant Holdings Co  (TSE:4929) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Adjuvant Holdings Co Cyclically Adjusted PS Ratio Related Terms


Adjuvant Holdings Co Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Adjuvant Holdings Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adjuvant Holdings Co Cyclically Adjusted PS Ratio Chart

Adjuvant Holdings Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.78 1.56 1.45 1.26 1.20

Adjuvant Holdings Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.17 1.22 1.19 1.19 1.14

TSE:4929 vs PG, CL, EL: Cyclically Adjusted PS Ratio Comparison

For the Household & Personal Products subindustry, Adjuvant Holdings Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adjuvant Holdings Co Cyclically Adjusted PS Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Adjuvant Holdings Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Adjuvant Holdings Co's Cyclically Adjusted PS Ratio falls into.


TSE:4929
62GF Score
Adjuvant Holdings Co Ltd TSE:4929
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adjuvant Holdings Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Adjuvant Holdings Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Adjuvant Holdings Co's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=131.391/113.6000*113.6000
=131.391

Current CPI (Jun. 2026) = 113.6000.

Adjuvant Holdings Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 147.201 98.000 170.633
201612 179.400 98.400 207.112
201703 137.727 98.100 159.488
201706 167.793 98.500 193.516
201709 154.630 98.800 177.793
201712 173.306 99.400 198.064
201803 145.943 99.200 167.128
201806 161.866 99.200 185.363
201809 164.222 99.900 186.743
201812 163.787 99.700 186.622
201903 156.683 99.700 178.527
201906 125.653 99.800 143.028
201909 151.398 100.100 171.816
201912 177.454 100.500 200.585
202003 132.539 100.300 150.114
202006 136.098 99.900 154.762
202009 138.888 99.900 157.935
202012 194.646 99.300 222.677
202103 141.282 99.900 160.657
202106 142.019 99.500 162.144
202109 138.347 100.100 157.005
202112 161.425 100.100 183.196
202203 110.230 101.100 123.859
202206 129.316 101.800 144.305
202209 142.135 103.100 156.610
202212 163.451 104.100 178.367
202303 112.290 104.400 122.185
202306 134.435 105.200 145.169
202309 142.550 106.200 152.483
202312 160.786 106.800 171.023
202403 117.245 107.200 124.245
202406 132.852 108.200 139.482
202409 126.865 108.900 132.340
202412 146.104 110.700 149.931
202503 105.707 111.100 108.086
202506 119.534 111.700 121.567
202509 112.139 112.000 113.741
202512 158.236 113.000 159.076
202603 86.462 112.700 87.152
202606 131.391 113.600 131.391

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Adjuvant Holdings Co (TSE:4929) Overvalued in 2026?

Based on GuruFocus' analysis, Adjuvant Holdings Co stock appears to be overvalued. The current stock price of 円745.00 is trading 4.7% above its estimated GF Value™ of 円711.32. GuruFocus considers Adjuvant Holdings Co to be Fairly Valued.

Key valuation signals for TSE:4929:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: 円711.32 vs. price of 円745.00 (4.7% above fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the TSE:4929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Adjuvant Holdings Co Business Description

Address 5-5-5 Shimoyamatedori, Chuo-ku, Hyogo Prefecture, Kobe City, JPN, 650-0011
Adjuvant Holdings Co Ltd, formerly Adjuvant Cosme Japan Co Ltd is engaged in the research, development, production, and sale of cosmetics in Japan. It offers skin care products, including cleansing products, facial cleansers, lotions, beauty essences, masks, moisturizing creams, makeup bases, makeup, and body care products among other products.
62GF Score

Get the complete analysis for TSE:4929

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円745.00
Price
円711.32
GF Value